Galen Management, LLC
CIK 1421162 · last filed 2017-09-19
Galen Management, LLC is a corporate insider who has filed 5 SEC Form 4 insider transactions across 2 companies since 2013. The most recent filing shows the insider sold $346.7M of TCMD on Sep 19, 2017. Across all open-market trades the lifetime net is −$378.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $27.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$27.49M
2
5
-$378.84M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TCMD | 10%+ Owner | 907,736 | $30.28 | $27.49M | -$378.60M | 4 | 2017-09-19 |
| ACURA PHARMACEUTICALS, INC (ACUR) Delisted | 10%+ Owner | 11,784,527 | — | — | -$236.4K | 1 | 2013-06-11 |
Recent Filings
5 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-09-19 | TCMD | Sell (S) | −11,178,000 | -$346.74M | EDGAR |
| 2017-06-29 | TCMD | Sell (S) | −800,000 | -$23.08M | EDGAR |
| 2017-06-22 | TCMD | Sell (S) | −332,000 | -$8.78M | EDGAR |
| 2016-08-04 | TCMD | Conv (C) | +18,974,532 | $0 | EDGAR |
| 2013-06-11 | ACURA PHARMACEUTICALS, INC (ACUR) Delisted | Sell (S) | −107,480 | -$236.4K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.